Advertisement
Singapore markets open in 4 hours 9 minutes
  • Straits Times Index

    3,343.35
    +11.65 (+0.35%)
     
  • S&P 500

    5,482.87
    +4.97 (+0.09%)
     
  • Dow

    39,164.06
    +36.26 (+0.09%)
     
  • Nasdaq

    17,858.68
    +53.53 (+0.30%)
     
  • Bitcoin USD

    61,467.93
    +656.17 (+1.08%)
     
  • CMC Crypto 200

    1,280.02
    +13.88 (+1.10%)
     
  • FTSE 100

    8,179.68
    -45.65 (-0.55%)
     
  • Gold

    2,338.20
    +25.00 (+1.08%)
     
  • Crude Oil

    81.88
    +0.98 (+1.21%)
     
  • 10-Yr Bond

    4.2880
    -0.0280 (-0.65%)
     
  • Nikkei

    39,341.54
    -325.53 (-0.82%)
     
  • Hang Seng

    17,716.47
    -373.46 (-2.06%)
     
  • FTSE Bursa Malaysia

    1,584.94
    -6.01 (-0.38%)
     
  • Jakarta Composite Index

    6,967.95
    -6,905.64 (-49.78%)
     
  • PSE Index

    6,390.58
    +77.47 (+1.23%)
     

Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)

On June 20, 2024, Bronwen Bastone, Chief People Officer of Enfusion Inc (NYSE:ENFN), executed a sale of 28,780 shares of the company, according to the SEC Filing. Following this transaction, the insider now owns 198,913 shares of the company.

Enfusion Inc (NYSE:ENFN) specializes in providing cloud-based investment management software and services. These solutions cater to asset managers and hedge funds, helping them streamline operations, increase transparency, and optimize their workflows.

Over the past year, the insider has sold a total of 63,830 shares and has not made any purchases. This recent transaction is part of a broader trend observed within the company, where there have been 28 insider sells and no insider buys over the past year.

ADVERTISEMENT

Shares of Enfusion Inc were trading at $8.13 on the day of the transaction. The company's market cap is currently $764.703 million. The price-earnings ratio stands at 277.33, significantly higher than both the industry median of 26.44 and the companys historical median.

According to the GF Value, the intrinsic value of Enfusion Inc is estimated at $11.97 per share, suggesting that the stock is significantly undervalued with a price-to-GF-Value ratio of 0.68.

The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.

Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)

This sale by the insider might be of interest to current and potential investors, providing insight into insider confidence and valuation perspectives at Enfusion Inc (NYSE:ENFN).

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.